Medication info

Neopharm Injection

Prescription medicationInjections
Ingredient · strength
L-Isoleucine›920mg / 100mLL-Leucine›945mg / 100mLL-Lysine Acetate›395mg / 100mLL-Methionine›44mg / 100mLL-Phenylalanine›30mg / 100mLL-Threonine›214mg / 100mLL-Tryptophan›70mg / 100mLL-Valine›890mg / 100mLL-Arginine›1537mg / 100mLL-Histidine›310mg / 100mLGlycine›540mg / 100mLL-Alanine›840mg / 100mLL-Proline›530mg / 100mLL-Aspartic Acid›20mg / 100mLL-Serine›260mg / 100mLL-Tyrosine›40mg / 100mL
Manufacturer / importer
Shinpoong Pharmaceutical Co., Ltd.
Appearance
An injection solution in a colorless, transparent glass vial containing a colorless to pale yellow, transparent liquid.
Packaging
250 milliliters/vial x 1
Approval status
Active

MFDS item code 199700026 · Notified 1997.04.17

Summary

Main use
Improvement of encephalopathy caused by chronic liver dysfunction
Who uses it
Adults
Adult dosage
○Adults: In general, administer 500 mL by intravenous infusion once. ○Infusion rate: Usually, administer each 500 mL over at least 180 minutes. ○Administration via a central vein: Mix 500 mL of this medicine with a carbohydrate-containing infusion solution or similar, and administer by continuous infusion into a central vein over 24 hours. Adjust the dose as appropriate according to age, symptoms, and body weight.

Ingredients

Manufacturer
Shinpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of encephalopathy caused by chronic liver dysfunction

  • Encephalopathy due to chronic liver failure
View approved original text

This medication helps improve the symptoms of encephalopathy caused by chronic liver failure. It is used to alleviate neurological issues arising from decreased liver function, stabilizing the patient's condition. Therefore, it is effective in treating encephalopathy due to chronic liver failure.

Dosage and Administration

Adult dosage

○Adults: In general, administer 500 mL by intravenous infusion once. ○Infusion rate: Usually, administer each 500 mL over at least 180 minutes. ○Administration via a central vein: Mix 500 mL of this medicine with a carbohydrate-containing infusion solution or similar, and administer by continuous infusion into a central vein over 24 hours. Adjust the dose as appropriate according to age, symptoms, and body weight.

Precautions

This medication must be used according to a doctor's instructions. Using it arbitrarily without a doctor's prescription can pose health risks. This medication should not be administered to patients with severe renal impairment or hyperazotemia. Furthermore, it should also not be used in patients with amino acid metabolism disorders aside from liver failure. It is also safe to avoid administering this medication to patients with metabolic disorders causing nitrogen utilization issues, patients with cachetic heart disease, patients with pulmonary edema, or those with oliguria or anuria. Patients with hypernatremia, hyperchloremia, or alkalosis, as well as those in a state of excessive fluid supply and patients with a history of myocardial infarction should not use this medication. Cautious administration is required for patients with severe acidosis, congestive heart failure, or severe heart disease, as well as those with edema due to sodium retention and patients with reduced kidney function. This medication contains sodium bisulfite which may cause allergic reactions or asthma attacks in individuals with sulfite allergies or asthma. Rarely, hypersensitivity reactions such as skin rashes may occur during administration, and in such cases, usage should be immediately discontinued. Gastrointestinal symptoms such as nausea or vomiting, chest discomfort, palpitations, rapid pulse, and elevated blood pressure can occasionally appear. Rapid infusion in large volumes may lead to acidosis, so caution should be exercised. Severe side effects such as chills, fever, headaches, dyspnea, respiratory arrest, shock, bronchospasm, and urinary tract spasm may also occur rarely. Various metabolic complications such as metabolic acidosis, hypophosphatemia, alkalosis, hyperglycemia, diabetes, dehydration, rebound hypoglycemia, elevated liver enzymes, vitamin deficiencies or excesses, electrolyte imbalances, or pediatric hyperammonemia may occur. Patients with impaired liver or kidney function may have elevated blood urea nitrogen (BUN) levels, necessitating caution. Patients with severe impaired liver function are at risk of serum amino acid imbalances, metabolic alkalosis, systemic azotemia, hyperammonemia, consciousness disturbances, or coma. When large doses are administered or in conjunction with electrolyte-containing solutions, careful monitoring of electrolyte balance is required. During overdose, metabolic alkalosis may occur, so preparations containing acidic ions should be used carefully. Administration to patients with kidney disease, lung disease, or severe heart disease should be done cautiously to avoid excessive fluid supply. Diabetic patients should frequently monitor their blood sugar levels while using this medication. Patients with hyponatremia and liver or kidney failure should adjust the dosage individually and carefully manage fluid balance and serum electrolyte levels. This medication can reduce the protein synthesis promoting effect of the specific antibiotic tetracycline when used in combination. Mixing vitamin B1 (thiamine) with this medication may reduce the effect of vitamin B1, so it is advisable not to use them together. The safety of this medication in pregnant women has not been sufficiently confirmed; thus it should only be administered cautiously when the therapeutic benefits outweigh the risks. For children, liver function may be immature, so maintaining lower concentrations for administration is preferable, and in infants, blood ammonia levels should be frequently monitored. Elderly patients often have diminished bodily functions, so the infusion rate should be slowed down and the dosage reduced for safe use. Since this medication contains electrolytes, careful attention to electrolyte balance is particularly important when large doses are administered or when used alongside other electrolyte solutions. Administer it slowly via IV injection, as rapid infusion can cause chills or vomiting and lead to significant amino acid loss via the kidneys. If stored in the refrigerator, it should be used within 24 hours, and it should not be used if the solution is cloudy or discolored. The preparation and administration of intravenous solutions should be done in an aseptic manner, paying close attention to the sterilization of syringes and equipment.

Side effects

  • Rash
  • nausea
  • vomiting
  • chest discomfort
  • palpitations
  • rapid pulse
  • increased blood pressure
  • acidosis
  • chills
  • fever
Show 26 more
  • headache
  • dyspnea
  • respiratory arrest
  • shock
  • bronchospasm
  • urinary tract spasm
  • metabolic acidosis
  • hypophosphatemia
  • alkalosis
  • hyperglycemia
  • diabetes
  • osmotic diuresis
  • dehydration
  • rebound hypoglycemia
  • elevated liver enzymes
  • vitamin deficiency
  • vitamin excess
  • electrolyte imbalance
  • pediatric hyperammonemia
  • elevated BUN
  • serum amino acid imbalance
  • metabolic alkalosis
  • systemic nitrogen retention
  • hyperammonemia
  • sensory loss
  • coma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air, kept away from direct sunlight, and ideally stored at room temperature. This will help maintain the medication's efficacy for a longer period.

Appearance and packaging

Appearance

An injection solution in a colorless, transparent glass vial containing a colorless to pale yellow, transparent liquid.

Package unit

250 milliliters/vial x 1

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.